← Eichor
Study identifier: NCT06942520 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME)

Condition: Diabetic Macular Edema  ·  Sponsor: Sierra Eye Associates

PhasePhase 2
Planned participants18
Who can joinAll sexes, 25 Years to 89 Years
Healthy volunteersNo

About this study

Phase 2 open label, randomized, active controlled, dose-ranging trial in adults with Center Involved - Diabetic Macular Edema (CI - DME)

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Research Study Coordinator  ·  775-329-0286  ·  jvannavong@sierraeyeassociates.com

Always discuss trial participation with your own doctor first.

Locations (1)

Sierra Eye AssociatesReno, Nevada, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06942520